Penwest Pharmaceuticals Articles
Endo buys US generics firm Qualitest for $1.2 billion
29 September 2010
Endo Pharma to buy Penwest for around $144 million; submits NDA for new formulation of oxymorphone
10 August 2010
Showing 1-2 of 2 articles
- 1
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
